FDA Inspection 1298666 — Novocure GmbH
The FDA completed an inspection of Novocure GmbH on December 19, 2025 in Baar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Baar (Switzerland)
Additional Details
Sponsor, Contract Research Organization